People chronically infected with the hepatitis C virus currently have only one treatment option: a combination of polyethylene glycol (PEG)-ylated interferon alpha and ribavirin (RBV). Not only does this drug regimen fail to eradicate the virus in about half of all patients who receive it, but even when [...]
